FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

PRYOR DANIEL A
2. Issuer Name and Ticker or Trading Symbol

Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP, Strategy & Business Dev.
(Last)          (First)          (Middle)

2711 CENTERVILLE ROAD, SUITE 400
3. Date of Earliest Transaction (MM/DD/YYYY)

11/15/2022
(Street)

WILMINGTON, DE 19808
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 11/15/2022  M  67421 A$45.06 143152 (1)D  
Common stock, par value $0.001 11/15/2022  S(2)  67421 (2)D$54.576 (3)75731 D  
Common stock, par value $0.001         932 I By 401k plan 
Common stock, par value $0.001         333 I By trust for daughter 
Common stock, par value $0.001         333 I By trust for daughter 
Common stock, par value $0.001         333 I By trust for son 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy) $45.06 11/15/2022  M     67421   (4)11/16/2023 Common stock, par value $.001 67421 $0.00 0 D  

Explanation of Responses:
(1) Holdings reflect the adjustments that occurred as of April 4, 2022 in connection with the spin-off of ESAB Corporation by the Issuer. In connection with the spin-off, each outstanding restricted stock unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded down to the nearest whole unit. In addition, holdings have been updated to reflect the impact of the one-for-three reverse stock split effected by the Issuer on April 4, 2022.
(2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
(3) The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $55.01, inclusive. The reporting person undertakes to provide to Enovis Corporation, any security holder of Enovis Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(4) The option vests in equal installments on the first, second and third anniversaries of the grant date, which was 11/15/2015

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
PRYOR DANIEL A
2711 CENTERVILLE ROAD
SUITE 400
WILMINGTON, DE 19808


EVP, Strategy & Business Dev.

Signatures
/s/ Brian P. Hanigan, attorney-in-fact11/17/2022
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Colfax (NYSE:CFX)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Colfax 차트를 더 보려면 여기를 클릭.
Colfax (NYSE:CFX)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Colfax 차트를 더 보려면 여기를 클릭.